Histopathologic Evidence of Tumor Regression in the Axillary Lymph Nodes of Patients Treated With Preoperative Chemotherapy Correlates With Breast Cancer Outcome

A Haid; A Makris; AC Wolff; AR Miller; B Fisher; B Fisher; Daniel W. Visscher; David L. Bouwman; DR McCready; G Bonnadonna; HM Kuerer; HM Kuerer; HM Kuerer; JR Broadwater; JS Abrams; Kathryn A. Carolin; KK Hunt; KS Nason; LA Newman; Lisa A. Newman; Mary A. Kosir; Michael White; N Hansen; Nat L. Pernick; Philip I. Philip; R Rouzier; SE Singletary; Susan Sipierski; TM Breslin; V Stearns; Volkan Adsay

Histopathologic Evidence of Tumor Regression in the Axillary Lymph Nodes of Patients Treated With Preoperative Chemotherapy Correlates With Breast Cancer Outcome

Authors: A Haid
A Makris
AC Wolff
AR Miller
B Fisher
B Fisher
Daniel W. Visscher
David L. Bouwman
DR McCready
G Bonnadonna
HM Kuerer
HM Kuerer
HM Kuerer
JR Broadwater
JS Abrams
Kathryn A. Carolin
KK Hunt
KS Nason
LA Newman
Lisa A. Newman
Mary A. Kosir
Michael White
N Hansen
Nat L. Pernick
Philip I. Philip
R Rouzier
SE Singletary
Susan Sipierski
TM Breslin
V Stearns
Volkan Adsay
Publication date: 1 January 2003
Publisher: 'Springer Science and Business Media LLC'
Doi

Abstract

Background: The benefits of primary tumor downstaging and assessment of chemoresponsiveness have resulted in expanded applications for induction chemotherapy. However, the pathologic evaluation and prognostic significance of response in preoperatively treated lymph nodes have not been defined.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/41400/1/10434_2003_Article_734.pd

Similar works

Full text

Available Versions

Crossref

Last time updated on 11/12/2019

Deep Blue Documents at the University of Michigan

oai:deepblue.lib.umich.edu:202...

Last time updated on 25/05/2012